Erkinheimo Tiina-Liisa, Sivula Anna, Lassus Heini, Heinonen Mira, Furneaux Henry, Haglund Caj, Butzow Ralf, Ristimäki Ari
Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland.
Gynecol Oncol. 2005 Oct;99(1):14-9. doi: 10.1016/j.ygyno.2005.04.047.
Cyclooxygenase-2 (COX-2) expression has been found to associate with poor prognosis in several types of carcinomas. HuR is an mRNA stability protein and it regulates the expression of COX-2.
We analyzed the expression of COX-2 and HuR in 64 mucinous ovarian carcinoma specimens by immunohistochemistry.
In mucinous tumors, high COX-2 protein expression was found in epithelial cancer cells in 39% (22/56) and in stromal cells in 24% (13/55) of the specimens. The expression of COX-2 in cancer cells correlated with high grade (P = 0.0285), but stromal COX-2 expression had no correlation with any clinical parameter tested. Cytoplasmic HuR protein expression was observed in cancer cells in 47% (27/57) and in stromal cells in 7% (4/56) of the mucinous tumors, and it correlated with COX-2 expression in the cancer cells (P = 0.0162) but not in the stroma.
Our results support the hypothesis that cytoplasmic HuR is connected to COX-2 expression in ovarian carcinoma, but that its role is restricted to the transformed epithelial cancer cells.
已发现环氧合酶-2(COX-2)的表达与几种类型的癌症预后不良相关。HuR是一种mRNA稳定性蛋白,它调节COX-2的表达。
我们通过免疫组织化学分析了64例黏液性卵巢癌标本中COX-2和HuR的表达。
在黏液性肿瘤中,39%(22/56)的标本上皮癌细胞和24%(13/55)的标本基质细胞中发现COX-2蛋白高表达。癌细胞中COX-2的表达与高级别相关(P = 0.0285),但基质COX-2表达与所检测的任何临床参数均无相关性。在47%(27/57)的黏液性肿瘤癌细胞和7%(4/56)的基质细胞中观察到细胞质HuR蛋白表达,并且它与癌细胞中COX-2的表达相关(P = 0.0162),但与基质中的COX-2表达无关。
我们的结果支持以下假设,即细胞质HuR与卵巢癌中COX-2的表达相关,但其作用仅限于转化的上皮癌细胞。